Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1975 3
1976 3
1977 3
1978 2
1981 1
1990 1
1994 3
1995 2
1998 3
2000 1
2001 1
2002 8
2003 2
2004 2
2005 1
2006 2
2007 2
2008 2
2009 3
2010 8
2011 7
2012 8
2013 12
2014 5
2015 8
2016 15
2017 10
2018 21
2019 17
2020 17
2021 29
2022 68
2023 73
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Results by year

Filters applied: . Clear all
Page 1
Neutrophils direct preexisting matrix to initiate repair in damaged tissues.
Fischer A, Wannemacher J, Christ S, Koopmans T, Kadri S, Zhao J, Gouda M, Ye H, Mück-Häusl M, Krenn PW, Machens HG, Fässler R, Neumann PA, Hauck SM, Rinkevich Y. Fischer A, et al. Among authors: gouda m. Nat Immunol. 2022 Apr;23(4):518-531. doi: 10.1038/s41590-022-01166-6. Epub 2022 Mar 30. Nat Immunol. 2022. PMID: 35354953 Free PMC article.
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST).
Gouda MA, Janku F, Wahida A, Buschhorn L, Schneeweiss A, Abdel Karim N, De Miguel Perez D, Del Re M, Russo A, Curigliano G, Rolfo C, Subbiah V. Gouda MA, et al. Ann Oncol. 2024 Mar;35(3):267-275. doi: 10.1016/j.annonc.2023.12.007. Epub 2023 Dec 23. Ann Oncol. 2024. PMID: 38145866 Review.
N-of-1 Trials in Cancer Drug Development.
Gouda MA, Buschhorn L, Schneeweiss A, Wahida A, Subbiah V. Gouda MA, et al. Cancer Discov. 2023 Jun 2;13(6):1301-1309. doi: 10.1158/2159-8290.CD-22-1377. Cancer Discov. 2023. PMID: 37070849 Free PMC article. Review.
Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.
Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH; ESC-EORP-HFA Heart Failure Long-Term Registry Investigators. Chioncel O, et al. Eur J Heart Fail. 2019 Nov;21(11):1338-1352. doi: 10.1002/ejhf.1492. Epub 2019 May 24. Eur J Heart Fail. 2019. PMID: 31127678 Free article.
Tissue-Agnostic Cancer Therapy Approvals.
Gouda MA, Subbiah V. Gouda MA, et al. Surg Oncol Clin N Am. 2024 Apr;33(2):243-264. doi: 10.1016/j.soc.2023.12.001. Epub 2023 Dec 26. Surg Oncol Clin N Am. 2024. PMID: 38401908 Review.
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
Shreenivas A, Janku F, Gouda MA, Chen HZ, George B, Kato S, Kurzrock R. Shreenivas A, et al. Among authors: gouda ma. NPJ Precis Oncol. 2023 Sep 29;7(1):101. doi: 10.1038/s41698-023-00449-x. NPJ Precis Oncol. 2023. PMID: 37773318 Free PMC article. Review.
340 results